{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:35:48Z","timestamp":1791527748448,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metagenomic next-generation sequencing (mNGS) enables simultaneous sequencing of DNA fragments for comprehensive pathogen identification. Pneumonia in immunocompromised patients\u2014characterized by atypical clinical manifestations and rapid progression\u2014poses diagnostic challenges. Conventional microbiological testing (CMT), which relies on pathogen culture and serological assays, is limited by prolonged turnaround times and suboptimal detection rates. This study was performed to evaluate the clinical utility of mNGS through comparative analysis with CMT in detecting pathogens among immunocompromised patients with pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study of 146 immunocompromised patients with suspected pneumonia. The mNGS and CMT results were systematically analyzed. Pathogen detection rates and microbial spectrum concordance were visualized using pie and bar charts. Diagnostic performance was compared using McNemar\u2019s test and Kappa (\u03ba) statistics for inter-method agreement. The sensitivity, specificity, accuracy, and area under the curve were calculated for pathogen-specific evaluations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>mNGS demonstrated superior detection efficacy, identifying pathogens in 98 cases versus 50 by CMT, with 48 overlapping positives. The microbial spectrum showed substantial differences: mNGS detected 73 bacterial, 46 fungal, and 45 viral pathogens, whereas CMT identified 38 bacterial, 27 fungal, and 21 viral agents. mNGS outperformed CMT across all infection types, including single-pathogen infections (bacterial, fungal, or viral only) and mixed infections (bacterial + fungal, bacterial + viral, fungal + viral, or bacterial + fungal + viral). Bacterial and fungal detections showed low inter-method concordance, while viral detection exhibited moderate agreement (\u03ba = 0.510, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Notably, mNGS achieved significantly higher detection rates for <jats:italic>Enterococcus faecalis<\/jats:italic> and <jats:italic>Pneumocystis jirovecii<\/jats:italic> in intensive care unit (ICU)-admitted patients with severe pneumonia (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Clinical outcomes improved in 45 patients following mNGS-guided therapeutic adjustments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>mNGS and CMT demonstrate complementary strengths in bacterial and fungal detection in immunocompromised patients with pneumonia. mNGS provides enhanced diagnostic accuracy for key pathogens such as <jats:italic>E. faecalis<\/jats:italic> and <jats:italic>P. jirovecii<\/jats:italic>, particularly in severe and ICU-admitted cases. As a high-throughput diagnostic tool, mNGS may improve pathogen detection and clinical management in immunocompromised populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1602636","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:45Z","timestamp":1758000945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic value of metagenomic next generation sequencing of bronchoalveolar lavage fluid in immunocompromised patients with pneumonia"],"prefix":"10.3389","volume":"15","author":[{"given":"Liu","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaDong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12879-018-3446-5","article-title":"Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow","volume":"18","author":"Bal","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1186424","article-title":"Clinical metagenomics-challenges and prospects","volume":"14","author":"Batool","year":"2023","journal-title":"Front. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"65-6, 69-70, 73","DOI":"10.3810\/pgm.2003.01.1351","article-title":"Community-acquired pneumonia in immunocompromised patients. Opportunistic infections to consider in differential diagnosis","volume":"113","author":"Cebular","year":"2003","journal-title":"Postgrad Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijid.2022.07.054","article-title":"Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: Systematic review and meta-analysis","volume":"122","author":"Chen","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/crj.13538","article-title":"Advantages and challenges of metagenomic sequencing for the diagnosis of pulmonary infectious diseases","volume":"16","author":"Chen","year":"2022","journal-title":"Clin. Respir. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.meegid.2013.04.026","article-title":"Population genetics and the evolution of virulence in Staphylococcus aureus","volume":"21","author":"Chua","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/prrv.2000.0007","article-title":"Bronchoalveolar lavage","volume":"1","author":"Connett","year":"2000","journal-title":"Paediatr. Respir. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s40265-021-01572-4","article-title":"The potential role of clinical metagenomics in infectious diseases: therapeutic perspectives","volume":"81","author":"d\u2019Humi\u00e8res","year":"2021","journal-title":"Drugs."},{"key":"B10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2021.09.012","article-title":"Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections","volume":"38","author":"Diao","year":"2021","journal-title":"J. Adv. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/clinchem\/hvad072","article-title":"Assessing the quality of metagenomic next-generation sequencing for pathogen detection in lower respiratory infections","volume":"69","author":"Diao","year":"2023","journal-title":"Clin. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13054-023-04608-1","article-title":"Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG","volume":"27","author":"Giacobbe","year":"2023","journal-title":"Crit. Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/1040841X.2019.1681933","article-title":"mNGS in clinical microbiology laboratories: on the road to maturity","volume":"45","author":"Han","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1271952","article-title":"Clinical utility of metagenomic next-generation sequencing in pathogen detection for lower respiratory tract infections and impact on clinical outcomes in southernmost China","volume":"13","author":"Hao","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00458-24","article-title":"The diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in critically ill patients with respiratory tract infections","volume":"12","author":"Hu","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110240","article-title":"The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform","volume":"9","author":"Jeon","year":"2014","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1223576","article-title":"Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis","volume":"13","author":"Jia","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MCP.0000000000000051","article-title":"Pneumonia in the immunocompromised host","volume":"20","author":"Letourneau","year":"2014","journal-title":"Curr. Opin. Pulm Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12879-023-08440-4","article-title":"Diagnostic performance of metagenomic next-generation sequencing for Pneumocystis jirovecii pneumonia","volume":"23","author":"Li","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12879-020-05179-0","article-title":"Identification of Enterococcus faecalis in a patient with urinary-tract infection based on metagenomic next-generation sequencing: a case report","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5884568","DOI":"10.1155\/2022\/5884568","article-title":"Diagnostic value of metagenomic next-generation sequencing for pneumonia in immunocompromised patients","volume":"2022","author":"Li","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.arcmed.2016.08.004","article-title":"Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients","volume":"47","author":"Long","year":"2016","journal-title":"Arch. Med. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"104691","DOI":"10.1016\/j.jcv.2020.104691","article-title":"ESCV Network on Next-Generation Sequencing. Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure","volume":"134","author":"L\u00f3pez-Labrador","year":"2021","journal-title":"J. Clin. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"126722","DOI":"10.1016\/j.micres.2021.126722","article-title":"An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation","volume":"247","author":"Mea","year":"2021","journal-title":"Microbiol. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ro.2021.10.009","article-title":"Pneumonia in the immunocompromised host","volume":"57","author":"Murali","year":"2022","journal-title":"Semin. Roentgenol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jinf.2021.01.029","article-title":"Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients","volume":"82","author":"Peng","year":"2021","journal-title":"J. Infect."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.567615","article-title":"Improving pulmonary infection diagnosis with metagenomic next generation sequencing","volume":"10","author":"Qian","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"116402","DOI":"10.1016\/j.diagmicrobio.2024.116402","article-title":"Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study","volume":"110","author":"Qin","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with pneumocystis jirovecii pneumonia","volume":"96","author":"Salzer","year":"2018","journal-title":"Respiration."},{"key":"B34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40291-024-00727-9","article-title":"Clinical metagenomic next-generation sequencing for diagnosis of central nervous system infections: advances and challenges","volume":"28","author":"Su","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e37845","DOI":"10.1097\/MD.0000000000037845","article-title":"Clinical application of metagenomic next-generation sequencing for the diagnosis of suspected infection in adults: A cross-sectional study","volume":"103","author":"Sun","year":"2024","journal-title":"Med. (Baltimore)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/14737159.2022.2071607","article-title":"The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review","volume":"22","author":"Tsang","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.913405","article-title":"Metagenomic next-generation sequencing is highly efficient in diagnosing pneumocystis jirovecii pneumonia in the immunocompromised patients","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1291980","DOI":"10.3389\/fcimb.2023.1291980","article-title":"Etiology of lower respiratory tract in pneumonia based on metagenomic next-generation sequencing: a retrospective study","volume":"13","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01488-22","article-title":"Application of metagenomic next-generation sequencing (mNGS) using bronchoalveolar lavage fluid (BALF) in diagnosing pneumonia of children","volume":"10","author":"Yang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1458316","article-title":"Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1602636\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:46Z","timestamp":1758000946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1602636\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":40,"alternative-id":["10.3389\/fcimb.2025.1602636"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1602636","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"article-number":"1602636"}}